1.      ALTAY, Derya. Çocuklarda Aminotransferaz Yüksekliği. Firat Tıp Dergisi, 2016, 21.3.

2.      Anania C, Luca E, Castro G, Chiesa C, Pacifico L. Liver involvement in pediatric celiac disease. World J Gastroenterol 2015; 21: 5813-5822.2

3.      Bugeac N, Pacht A, Mandel H, Iancu T, Tamir A, Srugo I, Shaoul R. The significance of isolated elevation of serum aminotransferases in infants and young children. Arch Dis Child. 2007 Dec;92(12):1109-12. doi: 10.1136/adc.2007.121194. Epub 2007 Jul 25. PMID: 17652319; PMCID: PMC2066067.

4.      Caropreso M, Fortunato G, Lenta S, Palmieri D, Esposito M, Vitale DF, Iorio R, Vajro P. Prevalence and long-term course of macro-aspartate aminotransferase in children. J Pediatr. 2009 May;154(5):744-8. doi: 10.1016/j.jpeds.2008.11.010. Epub 2008 Dec 25. PMID: 19111320.

5.      Costa JM, Pinto SM, Santos-Silva E, Moreira-Silva H. Incidental hypertransaminasemia in children-a stepwise approach in primary care. Eur J Pediatr. 2023 Apr;182(4):1601-1609. doi: 10.1007/s00431-023-04825-4. Epub 2023 Jan 26. PMID: 36697884; PMCID: PMC9877494.

6.      Dufour DR, Lott JA, Nolte FS, et al. Diagnosis and monitoring of hepaticinjury. Performance characteristics of laboratorytests. Clin Chem 2000; 46: 202749.

7.      England K, Thorne C, Pembrey L, Tovo PA, Newell ML. Age- and sex-related reference ranges of alanine aminotransferase levels in children: European paediatric HCV network. J Pediatr Gastroenterol Nutr. 2009 Jul;49(1):71-7. doi: 10.1097/MPG.0b013e31818fc63b. PMID: 19465871.

8.      European Association for Study of Liver. EASL Clinical Practice Guidelines: Wilson's disease. J Hepatol 2012; 56: 671-685 [PMID: 22340672 DOI:10.1016/j.jhep.2011.11.007]

9.      Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, Schilsky M, Cox D, Berr F. Diagnosis and pheno typic classification of Wilson disease. Liver Int 2003; 23: 139-142 [PMID: 12955875 DOI: 10.1034/j.1600-0676.2003.00824.x]

10.  Fernández Ventureira V, Ros Arnal I, Rodríguez Martínez G, García Rodríguez B, García Romero R, Ubalde Sainz E. Evaluation of liver function tests in the paediatric patient. An Pediatr (Engl Ed). 2021 Jun;94(6):359-365. doi: 10.1016/j.anpede.2020.06.014. Epub 2021 May 20. PMID: 34090632.

11.  Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ. 2005 Feb 1;172(3):367-79. doi: 10.1503/cmaj.1040752. PMID: 15684121; PMCID: PMC545762.

12.  Giboney PT. Mildly elevated liver transaminase levels in the asymptomatic patient. Am Fam Physician. 2005 Mar 15;71(6):1105-10. Erratum in: Am Fam Physician. 2005 Jul 1;72(1):41. PMID: 15791889.

13.  Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology. 2002 Oct;123(4):1367-84. doi: 10.1053/gast.2002.36061. PMID: 12360498.

14.  Iorio R, Sepe A, Giannattasio A, Cirillo F, Vegnente A. Hypertransaminasemia in childhood as a marker of genetic liver disorders. J Gastroenterol. 2005 Aug;40(8):820-6. doi: 10.1007/s00535-005-1635-7. PMID: 16143887.

15.  Krier M, Ahmed A. The asymptomatic outpatient with abnormal liver function tests. Clin Liver Dis. 2009 May;13(2):167-77. doi: 10.1016/j.cld.2009.02.001. PMID: 19442912.

16.  Lamireau T, McLin V, Nobili V, Vajro P. A practical approach to the child with abnormal liver tests. Clin Res Hepatol Gastroenterol. 2014 Jun;38(3):259-62. doi: 10.1016/j.clinre.2014.02.010. Epub 2014 Apr 13. PMID: 24736033.

17.  Malakouti M, Kataria A, Ali SK, Schenker S. Elevated Liver Enzymes in Asymptomatic Patients - What Should I Do? J Clin Transl Hepatol. 2017 Dec 28;5(4):394-403. doi: 10.14218/JCTH.2017.00027. Epub 2017 Sep 21. PMID: 29226106; PMCID: PMC5719197.

18.  Mieli-Vergani G, Vergani D, Baumann U, et al. Diagnosis and Management of Pediatric Autoimmüne Liver Disease: ESPGHAN Hepatology Committee Position Statement. J Pediatr Gastroenterol Nutr 2018;66:345-60.

19.  Newsome PN, Cramb R, Davison SM, Dillon JF, Foulerton M, Godfrey EM, Hall R, Harrower U, Hudson M, Langford A, Mackie A, Mitchell-Thain R, Sennett K, Sheron NC, Verne J, Walmsley M, Yeoman A. Guidelines on the management of abnormal liver blood tests. Gut. 2018 Jan;67(1):6-19. doi: 10.1136/gutjnl-2017-314924. Epub 2017 Nov 9. PMID: 29122851; PMCID: PMC5754852.

20.  Panganiban J, Kehar M, Ibrahim SH, Hartmann P, Sood S, Hassan S, Ramirez CM, Kohli R, Censani M, Mauney E, Cuda S, Karjoo S. 2. Obes Pillars. 2025 Feb 1;14:100164. doi: 10.1016/j.obpill.2025.100164. PMID: 40230708; PMCID: PMC11995806.

21.  Pfeiffer RF. Wilson’s disease. Semin Neurol 2007; 27: 123-132.

22.  Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell EE, Roden M, Romero-Gómez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN; NAFLD Nomenclature consensus group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023 Dec;79(6):1542-1556. doi: 10.1016/j.jhep.2023.06.003. Epub 2023 Jun 24. PMID: 37364790.

23.  Robert E. Druginduced liver disease.,In: Suchy FJ, Sokol RJ, Balistreri WF (eds) Liver Disease in Children, 2nd edition, Philadelphia 2001: 463491

24.  Ros Arnal I, Reyes Andrade J, Mercadal Hally M, Blesa Baviera LC, García Tirado D, Campuzano Martín SH, de la Calle Navarro E, Vegas Álvarez AM. Diagnostic action against hypertransaminasemia in paediatrics: Consensus document of Sociedad Española de Gastroenterología, Hepatología y Nutrición Pediátrica (SEGHNP), Asociación Española de Pediatría de Atención Primaria (AEPap) and Sociedad Española de Pediatría de Atención Primaria (SEPEAP). An Pediatr (Engl Ed). 2022 May;96(5):448.e1-448.e11. doi: 10.1016/j.anpede.2022.04.009. Epub 2022 May 27. PMID: 35644762.

25.  Schwimmer JB, Dunn W, Norman GJ, Pardee PE, Middleton MS, Kerkar N, Sirlin CB. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology. 2010 Apr;138(4):1357-64, 1364.e1-2. doi: 10.1053/j.gastro.2009.12.052. Epub 2010 Jan 11. PMID: 20064512; PMCID: PMC2846968.

26.  Serdaroğlu F, Koca T, Dereci S, Akçam M. The etiology of hypertransaminasemia in Turkish children. Bosn J Basic Med Sci. 2016 Feb 19;16(2):151-6. doi: 10.17305/bjbms.2016.982. PMID: 26894285; PMCID: PMC4852998.

27.  Serdaroğlu, F, Akçam, M.  Transaminaz yüksekliği olan çocuklarda klinik yaklaşım. Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi,2015; 26-33.

28.  Stolz A, Kaplowitz N. Biochemical tests for user disease. Zakim D, Boter TD. (Eds) In: Hepatology. 2nd ed. Philadelphia: WB Saunders Company; 1990: 63767

29.  Uygun A, Polat Z. Viral Hepatit Dışı Serum Transaminaz Düzeyinde Artışa Neden Olan Hastalıklar, Güncel Gastroenteroloji 2009;13/4: 21124

30.  Vajro P, Maddaluno S, Veropalumbo C. Persistent hypertransaminasemia in asymptomatic children: a stepwise approach. World J Gastroenterol. 2013 May 14;19(18):2740-51. doi: 10.3748/wjg.v19.i18.2740. PMID: 23687411; PMCID: PMC3653148